Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH -- Ignore unavailable to you. Want to Upgrade?

To: LFISKY who wrote (445)	12/19/1998 7:55:00 PM
From: TH	Respond to of 1084

Outstanding post. I wish to thank you for your effort. The ASTM thread benefits from posts like your and the Alaskan, as well as many others. I live in the area and would be willing to visit ASTM if the thread determines a need for this in the future. I currently make 20-40 trades per month, but I have a odd feeling that when the time comes I will be a bit resistant towards parting with my shares. As a previous post suggested, I have been thinking about violating my own trading rules to add more so I will have some to trade. Good Luck Disclaimer: The author could be of less than sound mind and should never be given any combination of alcohol, fishing rods, firearms, or matches. Cum granis salis.

To: LFISKY who wrote (445)	12/20/1998 9:12:00 AM
From: John G. Mueller	Respond to of 1084

It not about SI Its about the quality people that are members here. Thanks for your outstanding post. John

To: LFISKY who wrote (445)	12/20/1998 11:24:00 PM
From: Swami	Read Replies (1) \| Respond to of 1084

LFISKY, thanks for the summary. I'm already long, and intrigued sufficently to consider betting the ranch. Questions I wish had answers: 1) status of manufacturing: Does company have product ready to sell in Europe? 2) more on marketing/distribution: So far in generalities. Cobe's out but not completely. Company will continue to use their infrastructure for intro of first two products in Europe, but company will handle marketing to customers--the change (termination of 1993 agreement with Cobe) so as not to confuse customer down the road... Wish all of this were clearer. Does it mean Aastrom will eventually be developing its own distribution infrastructure? How will marketing be handled in U.S. when time comes? 3) more on competing technologies: Doc on Yahoo thread is quite satisfied with PBPC mobilization... (if I'm following correctly)..? 4) more on potential competitors in the cell expansion/replication arena: If this is so big, surely the big players are working on it, too. Any known trials in the works by potential competitors? How general are the company's patents--what barriers to entry can they provide? 5) timetable for U.S. approvals? 6) company's own revenue/earnings projections: I'm sure it's hockey stick, but would like to know the range of possibilities they see--and upon which the key investors placed their bets. 7) disposition towards being acquired? Pardon the long list. If answers are in the record somewhere, please point me towards them. Otherwise, let's see if we can continue to improve our understanding. I'll help where I can. After getting initial reactions on the thread, I'll e-mail remaining questions to company IR. All the best, SWAMI